RIPK1 and ischemia reperfusion injury: Similarly, the kinase activity of RIP1 has been implicated in ischemia-reperfusion injury (IRI) and genetic inactivation or chemical inhibition of RIP1 provides great protection from IRI-associated kidney injury22–24.